Local IL‐17A neutralization reduces experimental peri‐implant bone loss in type 2 diabetic rats
Journal of Periodontology · 20.11.2026
DOI: 10.1002/jper.70223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontology, online erschienen am 20.11.2026. Verfasst von Yuting Wu und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Background
The purpose of this study was to investigate whether local IL‐17A neutralization attenuates peri‐implant alveolar bone resorption in type 2 diabetes mellitus (T2DM) rats.
Methods
Thirty male Sprague‐Dawley rats with T2DM were randomly divided into three groups ( n = 10): a control group (without ligature‑induced peri‑implantitis), a peri‐implantitis (PI) group, and an anti‐IL‐17A group. Peri‐implant bone changes were evaluated by micro‐CT, osteoclastogenesis by TRAP staining, and inflammatory responses by H&E staining, qPCR, immunohistochemistry, and immunofluorescence.
Results
Micro‐CT revealed significantly greater linear and volumetric bone resorption in the PI group versus controls, which was reduced by IL‐17A neutralization. TRAP staining showed increased osteoclasts in the PI group, attenuated by IL‐17A neutralization. H&E staining confirmed exacerbated inflammation and bone resorption in the PI group, attenuated by anti‐IL‐17A. Inflammatory cytokine mRNAs were upregulated in the PI group, with IL‐17A exhibiting the most pronounced increase; IL‐17A neutralization reduced these levels, with IL‐17A showing the greatest reduction—confirmed at the protein level. Immunofluorescence showed increased MPO+ neutrophils, IL‐6+cells, and RANKL+ cells in the PI group versus controls, reduced by IL‐17A neutralization.
Conclusion
Our findings demonstrate that local IL‐17A blockade effectively attenuates peri‐implant alveolar bone resorption in T2DM rats by suppressing inflammatory responses and osteoclastogenesis, supporting this targeted strategy as a promising therapeutic approach for diabetic peri‐implantitis. However, as these are preclinical results, further studies are needed to validate the therapeutic relevance of this targeted strategy for diabetic peri‑implantitis.
Zitieren
APA
Wu, Y., Meng, Y., Ye, C., Lu, W., Yang, Y., & Zhao, X. (2026). Local IL‐17A neutralization reduces experimental peri‐implant bone loss in type 2 diabetic rats. Journal of Periodontology. https://doi.org/10.1002/jper.70223
Vancouver
Wu Y, Meng Y, Ye C, Lu W, Yang Y, Zhao X. Local IL‐17A neutralization reduces experimental peri‐implant bone loss in type 2 diabetic rats. Journal of Periodontology. 2026. doi:10.1002/jper.70223
BibTeX
@article{Wu2026,
author = {Wu, Yuting and Meng, Yiling and Ye, Changying and Lu, Wenjia and Yang, Yajie and Zhao, Xin},
title = {Local IL‐17A neutralization reduces experimental peri‐implant bone loss in type 2 diabetic rats},
journal = {Journal of Periodontology},
year = {2026},
doi = {10.1002/jper.70223}
}
EUVIMED